C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 84 filers reported holding C4 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,500 | -15.5% | 25,000 | +25.0% | 0.00% | – |
| Q2 2023 | $55,000 | +55.3% | 20,000 | +77.3% | 0.00% | -100.0% |
| Q1 2023 | $35,422 | -86.8% | 11,281 | -75.4% | 0.00% | -66.7% |
| Q4 2022 | $267,752 | -33.4% | 45,881 | 0.0% | 0.00% | -40.0% |
| Q3 2022 | $402,000 | +3.9% | 45,881 | -10.8% | 0.01% | 0.0% |
| Q2 2022 | $387,000 | -64.9% | 51,417 | +13.3% | 0.01% | -54.5% |
| Q1 2022 | $1,101,000 | -21.2% | 45,381 | +4.6% | 0.01% | -15.4% |
| Q4 2021 | $1,397,000 | – | 43,381 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |